Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

Clinical trial NCT06427642 · UNKNOWN

Trial details

NCT number: NCT06427642
Sponsor: Shandong Qilu Stem Cells Engineering Co., Ltd.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hypoxic-Ischemic Encephalopathy Bronchopulmonary Dysplasia Short Bowel Syndrome

Start date: 2022-04-01
Primary completion: 2024-05-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.